CVS Health Stock Plunges 10%, Wiping Out $12 Billion, As It Plans To Split Pharmacy From Insurance

CVS plans a tax-free spinoff of its pharmacy chain by the first half of 2028 and raised its 2026 adjusted profit floor to $8.20 a share.

Share
CVS Health Stock Plunges 10%, Wiping Out $12 Billion, As It Plans To Split Pharmacy From Insurance

CVS Health shares fell 9.98% to $82.29 in Wednesday trading, as of 9:55 a.m. ET, wiping out about $12 billion in market value, on the day the company said in an 8-K that it will split its pharmacy chain from its insurance business.

A tax-free spinoff targeted for 2028

The company plans to separate into an insurer-led health company and a standalone pharmacy chain through a tax-free spinoff, targeted for the first half of 2028. Existing shareholders would receive shares in both companies.

The insurance and pharmacy-benefit company keeps the CVS Health name under CEO David Joyner. The retail business, CVS Pharmacy, is to be led by Prem Shah. CNBC's account of the plan puts roughly 9,000 retail pharmacy locations in the standalone company.

CVS said additional leadership positions and board members for the two companies will be announced later.

Higher profit floor, bigger sales

Alongside the split, CVS raised its 2026 adjusted earnings-per-share floor to $8.20. Its quarterly sales reached $108.4 billion.

CVS runs pharmacies and clinics, a pharmacy benefits manager that administers drug coverage for employers and health plans, and the Aetna health insurer. The split would unwind the Aetna acquisition completed in 2018, as Joyner pursues a turnaround that includes cost cuts and store closures.

Up 15% before the drop

Before Wednesday's slide, CVS shares were up about 15% this year as of Tuesday's close, ahead of the S&P 500's gain of about 11%. They closed Tuesday up roughly 3.3% after a Financial Times report that the company was weighing a separation of its retail pharmacy arm.

Wednesday's decline was on pace to be the stock's biggest one-day drop since Jan. 27, when it fell 14.2%.

At Wednesday's price the company's market value stood near $105.2 billion, after the roughly $12 billion drop.

Sources

More on CVS Health

All CVS Health (CVS) coverage →